ISC markers have been extensively studied in colorectal cancer, where ASCL2 is known to control the fate of ISCs and colon cancer progenitor cells by regulating "stemness" genes such as LGR5 and controls self-renewal via R-spondin1/Wnt activation [15]. This evidence concerns the gene ASCL2 and colonic neoplasm.